DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc.
Stage unknownSouth San Francisco, CABiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 2
Financing history
1 rounds
- May 10, 2023Form D equity offering · $76.2M (form d sold) · 17 investorsFact SEC EDGAR Form D data sets (quarterly) · “Quanta Therapeutics, Inc. filed Form D/A: $76,192,272 sold of $89,098,282, Biotechnology”
Investors on record
2 edges
- Sofinnova Investments, Inc. board only, Maha Katabi (strongly supported) Inference sec.gov
- Vida Ventures Management board only, Rajul Jain (strongly supported) Inference sec.gov
People
3 officers, 5 directors
- Cameron Pitt Executive Officer/Director sec.gov
- Derek Metzger Executive Officer sec.gov
- Perry Nisen Executive Officer/Director sec.gov
- Rajul Jain Director Inference
- Maria Fardis Director Fact
- Maha Katabi Director Inference
- Ying Huang Director Fact
- Rajul Jain Director Fact
Timeline
1
- Jun 24, 2026Quanta Therapeutics, Inc. filed Form D/A: $76,192,272 sold of $89,098,282, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: true Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $76.2M Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $89.1M Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2023-05-10 Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 17 Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: TWO TOWER PLACE, FLOOR 17, SOUTH SAN FRANCISCO, CA, 94080 Jun 24, 2026 Fact SEC EDGAR Form D data sets (quarterly)